The correlation of MORC2 and the PAK1 pathway has also demonstrated in clinical studies showing that higher levels of PAK1 expression and phosphorylated MORC2 correlates with shorter overall survival and poor prognosis of clinical gastric cancer [62]. This evidence concerns the gene MORC2 and gastric cancer.